Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire
Luca Padua(Istituti di Ricovero e Cura a Carattere Scientifico), P. Tonali(Università Cattolica del Sacro Cuore), S. Mazza(University of Pavia), Amelia Evoli(Università Cattolica del Sacro Cuore), C. Punzi(Università Cattolica del Sacro Cuore), A. P. Batocchi(Casa Sollievo della Sofferenza), Pietro Caliandro(Università Cattolica del Sacro Cuore), Irene Aprile(Don Carlo Gnocchi Foundation)
Cited by 47
Related Papers
Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo‐controlled double‐blind study
|European Journal of Neurology|2006|233
Sleep Microstructure and EEG Epileptiform Activity in Patients with Juvenile Myoclonic Epilepsy
|Epilepsia|1992|108
Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study.
|PubMed|2000|105
Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements
|Neurological Sciences|2001|88
Neuroendocrinology of mood disorders.
|PubMed|2005|79